MAL has previously been reported to be a metastasis suppressor in esophageal cancer, gastric cancer, and head and neck squamous cell carcinoma and seems to confer survival advantages for relevant patients [53,56,67,68]. The gene discussed is MAL; the disease is gastric cancer.